Cardiovascular system effects of marijuana

Journal of Clinical Pharmacology

Volumn 42, Issue 11 SUPPL., 2002, Pages

  Jones, Reese T ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANANDAMIDE; ATROPINE; CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR ANTAGONIST; CANNABIS; CARBOXYHEMOGLOBIN; CATECHOLAMINE; DIGITALIS; DRONABINOL; NORADRENALIN; PROPANOL; RIMONABANT;

BLOOD PRESSURE; BLOOD VOLUME; BRADYCARDIA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR EFFECT; CATECHOLAMINE BLOOD LEVEL; CHOLINERGIC SYSTEM; CLINICAL RESEARCH; CLINICAL TRIAL; DISEASE ASSOCIATION; DRUG EXPOSURE; DRUG TOLERANCE; ELECTROCARDIOGRAM; EXERCISE; HEALTH HAZARD; HEART ATRIUM FIBRILLATION; HEART FUNCTION; HEART INFARCTION; HEART OUTPUT; HEART RATE; HEART WORK; HUMAN; HYPERTENSION; HYPOTENSION; NONHUMAN; ORTHOSTATIC HYPOTENSION; PRESSOR RESPONSE; REGULATORY MECHANISM; REVIEW; SMOKING; STROKE; SUPINE POSITION; SYMPATHETIC TONE; VALSALVA MANEUVER; VASCULAR RESISTANCE;

EID: 0036838392     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1552-4604.2002.tb06004.x     Document Type: Review

References (63)

1. Dewey WL: Cannabinoid pharmacology. Pharmacol Rev 1986;38:151-178.
2. Hollister LE: Health aspects of cannabis. Pharmacol Rev 1986;38:1-20.
3. Hollister LE: Cannabis - 1988. Acta Psychiatr Scand Suppl 1988; 345:108-118.
4. Beaconsfield P: Some cardiovascular effects of cannabis. Am Heart J 1974;87:143-146.
5. Beaconsfield P, Ginsburg J, Rainsbury R: Marihuana smoking: Cardiovascular effects in man and possible mechanisms. N Engl J Med 1972;287:209-212.
6. Kanakis C, Pouget M, Rosen KM: Lack of cardiovascular effects of Delta-9-tetrahydrocannabinol in chemically denervated men. Ann Intern Med 1979;91:571-574.
7. Clark SC, Greene C, Karr GW, MacCannell KL, Milstein SL: Cardiovascular effects of marihuana in man. Can J Physiol Pharmacol 1974;52:706-719.
8. Gottschalk LA, Aronow WS, Prakash R: Effect of marijuana and placebo-marijuana smoking on psychological state and on psychophysiological cardiovascular functioning in anginal patients. Biol Psychiatry 1977;12:255-266.
9. Johnstone RE, Lief PL, Kulp RA, Smith TC: Combination of Delta9-tetrahydrocannabinol with oxymorphone or pentobarbital: Effects on ventilatory control and cardiovascular dynamics. Anesthesiology 1975;42:674-684.
10. Malit LA, Johnstone RE, Bourke DI, Kulp RA, Klein V, Smith TC: Intravenous Delta9-tetrahydrocannabinol: Effects of ventilatory control and cardiovascular dynamics. Anesthesiology 1975;42:666-673.
11. Clark SC: Marihuana and the cardiovascular system. Pharmacol Biochem Behav 1975;3:299-306.
12. Benowitz NL, Jones RT: Cardiovascular effects of prolonged Delta-9-tetrahydrocannabinol ingestion. Clin Pharmacol Ther 1975;18:287-297.
13. Benowitz NL, Rosenberg J, Rogers W, Bachman J, Jones RT: Cardiovascular effects of intravenous Delta-9-tetrahydrocannabinol: Autonomic nervous mechanisms. Clin Pharmacol Ther 1979;25:440-446.
14. Kanakis C Jr, Pouget JM, Rosen KM: The effects of Delta-9-tetrahydrocannabinol (cannabis) on cardiac performance with and without beta blockade. Circulation 1976;53:703-707.
15. Hillard CJ: Endocannabinoids and vascular function. J Pharmacol Exp Ther 2000;294:27-32.
16. Martin BR: Identification of the endogenous cannabinoid system through integrative pharmacological approaches. J Pharmacol Exp Ther 2002;301:790-796.
17. Kumar RN, Chambers WA, Pertwee RG: Pharmacological actions and therapeutic uses of cannabis and cannabinoids. Anaesthesia 2001;56:1059-1068.
18. Gregg JM, Campbell RL, Levin KJ, Ghia J, Elliott RA: Cardiovascular effects of cannabinol during oral surgery. Anesth Analg 1976;55:203-213.
19. Jones RT, Benowitz NL, Herning RI: Clinical relevance of cannabis tolerance and dependence. J Clin Pharmacol 1981;21:143S-152S.
20. Mathew RJ, Wilson WH, Humphreys D, Lowe JV, Wiethe KE: Middle cerebral artery velocity during upright posture after marijuana smoking. Acta Psychiatr Scand 1992;86:173-178.
21. Gash A, Karliner JS, Janowsky D, Lake CR: Effects of smoking marihuana on left ventricular performance and plasma norepinephrine: Studies in normal men. Ann Intern Med 1978;89:448-452.
22. Aronow WS, Cassidy J: Effect of marihuana and placebomarihuana smoking on angina pectoris. N Engl J Med 1974;291:65-67.
23. Aronow WS, Cassidy J: Effect of smoking marihuana and of a high-nicotine cigarette on angina pectoris. Clin Pharmacol Ther 1975;17:549-554.
24. Horowitz LG, Nersasian RR: A review of marijuana in relation to stress mechanisms in the dental patient. J Am Dent Assoc 1978;96:983-986.
25. Sulkowski A, Vachon L, Rich ES Jr: Propranolol effects on acute marihuana intoxication in man. Psychopharmacology (Berl) 1977;52:47-53.
26. Graham JD, Li DM: Cardiovascular and respiratory effects of cannabis in cat and rat. J Pharmacol 1973;49:1-10.
27. Li DM: Cardiovascular and respiratory effects of cannabis extracts and 1-tetra-hydrocannabinol (1-THC). Br J Pharmacol 1973;47:627P.
28. Mathew RJ, Wilson WH: Acute changes in cerebral blood flow after smoking marijuana. Life Sci 1993;52:757-767.
29. Adams MD, Earnhardt JT, Dewey WL, Harris LS: Vasoconstrictor actions of Delta8- and Delta9-tetrahydrocannabinol in the rat. J Pharmacol Exp Ther 1976;196:649-656.
30. Kochar MS, Hosko MJ: Electrocardiographic effects of marihuana. JAMA 1973;225:25-27.
31. Roth WT, Tinldeinberg JR, Kopell BS, Hollister LE: Continuous electrocardiographic monitoring during marihuana intoxication. Clin Pharmacol Ther 1973;14:533-540.
32. Benowitz NL, Jones RT: Cardiovascular and metabolic considerations in prolonged cannabinoid administration in man. J Clin Pharmacol 1981;21:214S-223S.
33. Nowlan R, Cohen S: Tolerance to marijuana: Heart rate and subjective "high." Clin Pharmacol Ther 1977;22:550-556.
34. Cohen S: The 94-day cannabis study, Ann N Y Acad Sci 1976; 282:211-220.
35. Greenberg I, Kuehnle J, Mendelson JH, Bernstein JG: Effects of marihuana use on body weight and caloric intake in humans, Psychopharmacology (Berl) 1976;49:79-84.
36. Benowitz NL, Jones RT: Prolonged Delta-9-tetrahydrocarnnabinol ingestion: Effects of sympathomimetic amines and autonomic blockades. Clin Pharmacol Ther 1977;21:336-342.
37. Bachs L, Morland H: Acute cardiovascular fatalities following cannabis use, Forensic Sci Int 2001;124:200-203.
38. Mittleman MA, Lewis RA, Maclure M, Sherwood IB, Muller JE: Triggering myocardial infarction by marijuana, Circulation 2001;103:2805-2809.
39. Servoss SJ, Januzzi JL, Muller JE: Triggers of acute coronary syndromes, Prog Cardiovasc Dis 2002;44:369-380.
40. Johnson S, Domino EF: Some cardiovascular effects of marihuana smoking in normal volunteers. Clin Pharmacol Ther 1971;12:762-768.
41. Miller RH, Dhingra RC, Kanakis C Jr, Amat-y-Leon F, Rosen KM: The electrophysiological effects of Delta-9-tetrahydrocannabinol (cannabis) on cardiac conduction in man. Am Heart J 1977;94: 740-747.
42. Petronis KR, Anthony JC: An epidemiologic investigation of marijuana- and cocaine-related palpitations, Drug Alcohol Depend 1989; 23:219-226.
43. Kosior DA, Filipiak KJ, Stolarz P, Opolski G: Paroxysmal atrial fibrillation following marijuana intoxication: A two-case report of possible association, Int J Cardiol 2001;78:183-184.
44. Singh GK: Atrial fibrillation associated with marijuana use, Pediatr Cardiol 2000;21:284.
45. Nahas GG: Cannabis arteritis. N Engl J Med 1971;284:113.
46. Disdier P, Granel B, Serratrice J, Constans J, Michon-Pasturel U, Hachulla E, et al: Cannabis arteritis revisited - Ten new case reports. Angiology 2001;52:1-5.
47. Barnes D, Palace J, O'Brien MD: Stroke following marijuana smoking. Stroke 1992;23:1381.
48. Cooles P, Michaud R: Stroke after heavy cannabis smoking. Postgrad Med J 1987;63:511.
49. Lawson TM, Rees A: Stroke and transient ischaemic attacks in association with substance abuse in a young man. Postgrad Med J 1996;72:692-693.
50. Zachariah SB: Stroke after heavy marijuana smoking. Stroke 1991;22:406-409.
51. Mouzak A, Agathos P, Kerezoudi E, Mantas A, Vourdeli-Yiannakoura E: Transient ischemic attack in heavy cannabis smokers - How 'safe' is it? Eur Neurol 2000;44:42-44.
52. Mathew RJ, Wilson WH: Substance abuse and cerebral blood flow. Am J Psychiatry 1991;148:292-305.
53. Herning RI, Better WE, Tate K, Cadet JL: Marijuana abusers are at increased risk for stroke: Preliminary evidence from cerebrovascular perfusion data. Ann N Y Acad Sci 2001;939:413-415.
54. Hardman HF, Domino EF, Seevers MH: General pharmacological actions of some synthetic tetrahydrocannabinol derivatives, Pharmacol Rev 1971;23:295-315.
55. Fredericks AB, Benowitz NL, Savanapridi CY: The cardiovascular and autonomic effects of repeated administration of Delta-9-tetrahydrocannabinol to rhesus monkeys. J Pharmacol Exp Ther 1981;216:247-253.
56. Kunos G, Batkai S: Novel physiologic functions of endocannabinoids as revealed through the use of mutant mice. Neurochem Res 2001;26:1015-1021.
57. Kunos G, Jarai Z, Varga K, Liu J, Wang L, Wagner JA: Cardiovascular effects of endocannabinoids - The plot thickens. Prostaglandins Other Lipid Mediat 2000;61:71-84.
58. Wagner JA, Varga K, Kunos G: Cardiovascular actions of cannabinoids and their generation during shock. J Mol Med 1998;76: 824-836.
59. Kunos G, Jarai Z, Batkai S, Goparaju SK, Ishac EJ, Liu J, et al: Endocannabinoids as cardiovascular modulators. Chem Phys Lipids 2000;108:159-168.
60. Breivogel CS, Griffin G, Di Marzo V, Martin BR: Evidence for a new G protein-coupled cannabinoid receptor in mouse brain. Mol Pharmacol 2001;60:155-163.
61. Jarai Z, Wagner JA, Varga K, Lake KD, Compton DR, Martin BR, et al: Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors. Proc Natl Acad Sci USA 1999;96:14136-14141.
62. Batkai S, Jarai Z, Wagner JA, Goparaju SK, Varga K, Liu J, et al: Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis. Nat Med 2001;7:827-832.
63. Shah V: Portal hypertension and the hyperdynamic circulation: Nitric oxide in a haze of cannabinoid smoke, Hepatology 2001;34:1060-1061.